| Product Code: ETC12012305 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Norway`s import market for drugs to combat schistosomiasis showed significant growth in 2024, with key exporting countries including the UK, Germany, USA, Denmark, and Metropolitan France. The market concentration, as measured by the HHI index, remained low, indicating a diverse range of sources for these important pharmaceutical products. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 3.86%, while the impressive growth rate of 27.79% from 2023 to 2024 suggests a rising demand for these drugs in Norway.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Drugs for Schistosomiasis Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Drugs for Schistosomiasis Market Revenues & Volume, 2021 & 2031F |
3.3 Norway Drugs for Schistosomiasis Market - Industry Life Cycle |
3.4 Norway Drugs for Schistosomiasis Market - Porter's Five Forces |
3.5 Norway Drugs for Schistosomiasis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Norway Drugs for Schistosomiasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Norway Drugs for Schistosomiasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Norway Drugs for Schistosomiasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Norway Drugs for Schistosomiasis Market Trends |
6 Norway Drugs for Schistosomiasis Market, By Types |
6.1 Norway Drugs for Schistosomiasis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Praziquantel, 2021 - 2031F |
6.1.4 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Oxamniquine, 2021 - 2031F |
6.1.5 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Metrifonate, 2021 - 2031F |
6.1.6 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Artesunate, 2021 - 2031F |
6.2 Norway Drugs for Schistosomiasis Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.2.3 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.2.4 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.2.5 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Government Programs, 2021 - 2031F |
6.3 Norway Drugs for Schistosomiasis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.3.5 Norway Drugs for Schistosomiasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Norway Drugs for Schistosomiasis Market Import-Export Trade Statistics |
7.1 Norway Drugs for Schistosomiasis Market Export to Major Countries |
7.2 Norway Drugs for Schistosomiasis Market Imports from Major Countries |
8 Norway Drugs for Schistosomiasis Market Key Performance Indicators |
9 Norway Drugs for Schistosomiasis Market - Opportunity Assessment |
9.1 Norway Drugs for Schistosomiasis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Norway Drugs for Schistosomiasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Norway Drugs for Schistosomiasis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Norway Drugs for Schistosomiasis Market - Competitive Landscape |
10.1 Norway Drugs for Schistosomiasis Market Revenue Share, By Companies, 2024 |
10.2 Norway Drugs for Schistosomiasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |